DNA Ginkgo Bioworks Holdings, Inc.
NYSE · SEC CIK 1830214 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $3.71M 16 sales by 5 insiders
- Filings on record
- 441 since 2021-09-20, latest 2026-09-16 16:06
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Kelly Jason R | See remarks, Dir | — | $1.37M |
| Canton Barry | 10% | — | $977.6K |
| Shetty Reshma P. | See remarks, Dir, 10% | — | $977.6K |
| Coen Steven P. | See remarks | — | $348.2K |
| HENRY CHRISTIAN O | Dir | — | $35.4K |
Transactions 662
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-10-24 | 2022-10-20+ | DNA | Kelly Jason R | See remarks, Dir | S - Sale | $2.45 | -398.1K | 24.16M | -2% | -$977.2K |
| MI | 2022-10-20 | 2022-10-18+ | DNA | Canton Barry | 10% | S - Sale | $2.57 | -409.9K | 24.77M | -2% | -$1.05M |
| M | 2022-10-20 | 2022-10-18+ | DNA | Canton Barry | 10% | S - Sale | $2.57 | -409.9K | 24.77M | -2% | -$1.05M |
| M | 2022-10-20 | 2022-10-18+ | DNA | Shetty Reshma P. | See remarks, Dir, 10% | S - Sale | $2.57 | -409.9K | 24.77M | -2% | -$1.05M |
| MI | 2022-10-20 | 2022-10-18+ | DNA | Shetty Reshma P. | See remarks, Dir, 10% | S - Sale | $2.57 | -409.9K | 24.77M | -2% | -$1.05M |
| M | 2022-10-20 | 2022-10-18+ | DNA | Kelly Jason R | See remarks, Dir | S - Sale | $2.57 | -409.9K | 24.56M | -2% | -$1.05M |
| M | 2022-10-18 | 2022-10-14+ | DNA | Shetty Reshma P. | See Remarks, Dir, 10% | S - Sale | $2.63 | -411.3K | 25.16M | -2% | -$1.08M |
| MI | 2022-10-18 | 2022-10-14+ | DNA | Shetty Reshma P. | See Remarks, Dir, 10% | S - Sale | $2.63 | -411.3K | 25.16M | -2% | -$1.08M |
| M | 2022-10-18 | 2022-10-14+ | DNA | Canton Barry | 10% | S - Sale | $2.63 | -411.3K | 24.97M | -2% | -$1.08M |
| MI | 2022-10-18 | 2022-10-14+ | DNA | Canton Barry | 10% | S - Sale | $2.63 | -411.3K | 24.97M | -2% | -$1.08M |
| M | 2022-10-18 | 2022-10-14+ | DNA | Kelly Jason R | See remarks, Dir | S - Sale | $2.63 | -411.3K | 25.16M | -2% | -$1.08M |
| MI | 2022-10-14 | 2022-10-12+ | DNA | Shetty Reshma P. | See Remarks, Dir, 10% | S - Sale | $2.78 | -418.3K | 25.38M | -2% | -$1.16M |
| M | 2022-10-14 | 2022-10-12+ | DNA | Shetty Reshma P. | See Remarks, Dir, 10% | S - Sale | $2.78 | -418.3K | 25.38M | -2% | -$1.16M |
| M | 2022-10-14 | 2022-10-12+ | DNA | Kelly Jason R | See remarks, Dir | S - Sale | $2.78 | -418.3K | 25.59M | -2% | -$1.16M |
| MI | 2022-10-14 | 2022-10-12+ | DNA | Canton Barry | 10% | S - Sale | $2.78 | -418.3K | 25.59M | -2% | -$1.16M |
| M | 2022-10-14 | 2022-10-12+ | DNA | Canton Barry | 10% | S - Sale | $2.78 | -418.3K | 25.38M | -2% | -$1.16M |
| M | 2022-10-12 | 2022-10-10+ | DNA | Canton Barry | 10% | S - Sale | $2.88 | -414.0K | 25.80M | -2% | -$1.19M |
| MI | 2022-10-12 | 2022-10-10+ | DNA | Canton Barry | 10% | S - Sale | $2.88 | -414.0K | 25.80M | -2% | -$1.19M |
| M | 2022-10-12 | 2022-10-10+ | DNA | Shetty Reshma P. | See remarks, Dir, 10% | S - Sale | $2.88 | -414.0K | 25.80M | -2% | -$1.19M |
| MI | 2022-10-12 | 2022-10-10+ | DNA | Shetty Reshma P. | See remarks, Dir, 10% | S - Sale | $2.88 | -414.0K | 25.80M | -2% | -$1.19M |
| M | 2022-10-12 | 2022-10-10+ | DNA | Kelly Jason R | See Remarks, Dir | S - Sale | $2.88 | -414.0K | 25.80M | -2% | -$1.19M |
| DMA | 2022-10-07 | 2022-09-30+ | DNA | Fallon Marie E. | See remarks | M - OptEx | — | +232.5K | 6,134 | New | — |
| DA | 2022-10-07 | 2022-10-03 | DNA | Fallon Marie E. | See remarks | S - Sale+OE | $3.12 | -2,722 | 229.8K | -1% | -$8,493 |
| 2022-10-07 | 2022-10-06 | DNA | Fallon Marie E. | See Remarks | S - Sale | $3.25 | -102.3K | 127.5K | -44% | -$332.3K | |
| D | 2022-10-07 | 2022-10-05 | DNA | Dmytruk Mark E. | See remarks | M - OptEx | — | +618.2K | 627.3K | +6,792% | — |
| D | 2022-10-07 | 2022-10-06 | DNA | Dmytruk Mark E. | See remarks | S - Sale+OE | $3.25 | -279.3K | 348.1K | -45% | -$907.6K |
| DM | 2022-10-04 | 2021-10-01+ | DNA | Shetty Reshma P. | See Remarks, Dir, 10% | M - OptEx | — | +26.56M | 773.5K | New | — |
| DI | 2022-10-04 | 2022-10-03 | DNA | Shetty Reshma P. | See Remarks, Dir, 10% | S - Sale+OE | $3.12 | -343.1K | 26.21M | -1% | -$1.07M |
| D | 2022-10-04 | 2022-10-03 | DNA | Shetty Reshma P. | See Remarks, Dir, 10% | S - Sale+OE | $3.12 | -343.1K | 26.21M | -1% | -$1.07M |
| DMI | 2022-10-04 | 2021-10-01+ | DNA | Shetty Reshma P. | See Remarks, Dir, 10% | M - OptEx | — | +26.56M | 773.5K | New | — |
| D | 2022-10-04 | 2022-10-03 | DNA | Fallon Marie E. | See Remarks | S - Sale+OE | $3.12 | -2,722 | 494.2K | -0.5% | -$8,493 |
| DM | 2022-10-04 | 2021-10-01+ | DNA | Fallon Marie E. | See Remarks | M - OptEx | — | +496.9K | 6,134 | New | — |
| D | 2022-10-04 | 2022-10-03 | DNA | Dmytruk Mark E. | See Remarks | S - Sale+OE | $3.12 | -7,259 | 9,102 | -44% | -$22.6K |
| D | 2022-10-04 | 2022-09-30 | DNA | Dmytruk Mark E. | See Remarks | M - OptEx | — | +16.4K | 16.4K | New | — |
| D | 2022-10-04 | 2022-10-03 | DNA | Kelly Jason R | See remarks, Dir | S - Sale+OE | $3.12 | -343.1K | 26.21M | -1% | -$1.07M |
| DM | 2022-10-04 | 2022-09-30+ | DNA | Kelly Jason R | See remarks, Dir | M - OptEx | — | +26.56M | 26.56M | New | — |
| DM | 2022-10-04 | 2021-10-01+ | DNA | Canton Barry | 10% | M - OptEx | — | +26.56M | 26.56M | New | — |
| DMI | 2022-10-04 | 2021-10-01+ | DNA | Canton Barry | 10% | M - OptEx | — | +26.56M | 26.56M | New | — |
| DI | 2022-10-04 | 2022-10-03 | DNA | Canton Barry | 10% | S - Sale+OE | $3.12 | -343.1K | 26.21M | -1% | -$1.07M |
| D | 2022-10-04 | 2022-10-03 | DNA | Canton Barry | 10% | S - Sale+OE | $3.12 | -343.1K | 26.21M | -1% | -$1.07M |
| D | 2022-08-04 | 2022-08-02 | DNA | Hannan Kathy Hopinkah | Dir | A - Grant | $0.00 | +57.0K | 62.0K | +1,140% | $0 |
| D | 2022-06-13 | 2022-06-10 | DNA | HENRY CHRISTIAN O | Dir | A - Grant | $0.00 | +70.9K | 1.38M | +5% | $0 |
| D | 2022-06-13 | 2022-06-10 | DNA | Kewalramani Reshma | Dir | A - Grant | $0.00 | +70.9K | 70.9K | New | $0 |
| D | 2022-06-13 | 2022-06-10 | DNA | Belldegrun Arie | Dir | A - Grant | $0.00 | +70.9K | 89.7K | +378% | $0 |
| D | 2022-06-13 | 2022-06-10 | DNA | Sankar Shyam | Dir | A - Grant | $0.00 | +70.9K | 1.33M | +6% | $0 |
| D | 2022-06-13 | 2022-06-10 | DNA | SLOAN HARRY | Dir | A - Grant | $0.00 | +70.9K | 70.9K | New | $0 |
| D | 2022-06-13 | 2022-06-10 | DNA | DEKKERS MARIJN E | Dir | A - Grant | $0.00 | +70.9K | 2.19M | +3% | $0 |
| 2022-03-14 | 2022-03-11 | DNA | DEKKERS MARIJN E | Dir | A - Grant | $0.00 | +1.75M | 2.12M | +466% | $0 | |
| 2022-03-14 | 2022-03-11 | DNA | Sankar Shyam | Dir | A - Grant | $0.00 | +1.03M | 1.26M | +438% | $0 | |
| 2022-03-14 | 2022-03-11 | DNA | HENRY CHRISTIAN O | Dir | A - Grant | $0.00 | +1.07M | 1.31M | +457% | $0 | |
| DI | 2022-03-04 | 2022-03-02 | DNA | Ott David C. | 10% | J - Other | — | -288.00M | 51.06M | -85% | — |
| DI | 2021-12-08 | 2021-12-06 | DNA | Canton Barry | 10% | C - Cnv Deriv | — | +200.0K | 200.0K | New | — |
| DI | 2021-12-08 | 2021-12-07 | DNA | Canton Barry | 10% | G - Gift | $0.00 | -200.0K | 0 | -100% | $0 |
| DI | 2021-12-08 | 2021-12-07 | DNA | Shetty Reshma P. | See Remarks, Dir, 10% | G - Gift | $0.00 | -200.0K | 0 | -100% | $0 |
| DI | 2021-12-08 | 2021-12-06 | DNA | Shetty Reshma P. | See Remarks, Dir, 10% | C - Cnv Deriv | — | +200.0K | 200.0K | New | — |
| D | 2021-12-08 | 2021-12-06 | DNA | Kelly Jason R | See Remarks, Dir | C - Cnv Deriv | — | +150.0K | 150.0K | New | — |
| D | 2021-12-08 | 2021-12-07 | DNA | Kelly Jason R | See Remarks, Dir | G - Gift | $0.00 | -150.0K | 0 | -100% | $0 |
| D | 2021-09-22 | 2021-09-16 | DNA | Eagle Equity Partners III, LLC | Dir, 10%, *Dir by Deputization | D - Sale to Iss | — | -11.53M | 31.59M | -27% | — |
| 2021-09-20 | 2021-09-16 | DNA | DEKKERS MARIJN E | Dir | A - Grant | — | +375.0K | 375.0K | New | — | |
| I | 2021-09-20 | 2021-09-16 | DNA | DEKKERS MARIJN E | Dir | A - Grant | — | +5.78M | 5.78M | New | — |
| 2021-09-20 | 2021-09-16 | DNA | HENRY CHRISTIAN O | Dir | A - Grant | — | +234.5K | 234.5K | New | — | |
| 2021-09-20 | 2021-09-16 | DNA | Sankar Shyam | Dir | A - Grant | — | +234.5K | 234.5K | New | — |
Purchase Sale Sale after option exercise All abbreviations